First, Do No Harm: Buprenorphine Use for Pain Associated with Chronic Diseases
DOI:
https://doi.org/10.46570/utjms-2024-1184Keywords:
opioid use disorder, chronic disease, buprenorphine, do no harm, SymposiumReferences
Dalal S, Chitneni A, Berger AA, Orhurhu V, Dar B, Kramer B, Nguyen A, Pruit J, Halsted C, Kaye AD, Hasoon J. Buprenorphine for Chronic Pain: A Safer Alternative to Traditional Opioids. Health Psychol Res. 2021 Aug 6;9(1):27241. doi: 10.52965/001c.27241. PMID: 34746493; PMCID: PMC8567798.
Prince E, Loeser P, Early M, Carroll CP, Lanzkron S, Pecker LH. "Buprenorphine, It Works so Differently": Adults with Sickle Cell Disease Describe Transitioning to Buprenorphine for Treatment of Chronic Pain. J Pain. 2023 Sep 22:S1526-5900(23)00542-4. doi: 10.1016/j.jpain.2023.09.014. Epub ahead of print. PMID: 37742907.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Amanda Springer, Victoria Kelly (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).